Petmed Express Inc (PETS)

$4.11

-0.11

(-2.61%)▲

Market is closed - opens 7 PM, 19 Apr 2024

Insights on Petmed Express Inc

  • Decreasing Revenue

    Revenue is down for the last 4 quarters, 78.24M → 65.31M (in $), with an average decrease of 5.8% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -70.0K → -2.02M (in $), with an average decrease of 1397.9% per quarter

  • Vs BIMI

    In the last 1 year, Bimi International Medical Inc has given 117.2% return, outperforming this stock by 190.2%

Performance

  • $4.06
    $4.25
    $4.11
    downward going graph

    1.34%

    Downside

    Day's Volatility :4.59%

    Upside

    3.29%

    downward going graph
  • $4.01
    $15.80
    $4.11
    downward going graph

    2.43%

    Downside

    52 Weeks Volatility :74.62%

    Upside

    73.99%

    downward going graph

Returns

PeriodPetmed Express IncSector (Consumer Discretionary)Index (Russel 2000)
3 Months
-38.3%
-0.5%
0.0%
6 Months
-58.38%
9.0%
0.0%
1 Year
-72.98%
16.3%
-1.5%
3 Years
-86.27%
-4.2%
-21.8%

Highlights

Market Capitalization
88.2M
Book Value
$5.57
Dividend Share
1.2
Dividend Yield
13.07%
Earnings Per Share (EPS)
-0.3
PEG Ratio
2.58
Wall Street Target Price
7.75
Profit Margin
-2.25%
Operating Margin TTM
-0.6%
Return On Assets TTM
-2.64%
Return On Equity TTM
-4.83%
Revenue TTM
270.5M
Revenue Per Share TTM
13.3
Quarterly Revenue Growth YOY
8.6%
Gross Profit TTM
78.1M
EBITDA
-2.1M
Diluted Eps TTM
-0.3
Quarterly Earnings Growth YOY
-0.59
EPS Estimate Current Year
-0.04
EPS Estimate Next Year
0.05
EPS Estimate Current Quarter
0.02
EPS Estimate Next Quarter
0.01

Analyst Recommendation

Sell
    14%Buy
    28%Hold
    57%Sell
Based on 7 Wall street analysts offering stock ratings for Petmed Express Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
1
7
7
Hold
2
1
1
Sell
4
1
1

Analyst Forecast

What analysts predicted

Upside of 88.56%

Current $4.11
Target $7.75

Company Financials

FY18Y/Y Change
Revenue
273.8M
↑ 9.88%
Net Income
37.3M
↑ 56.53%
Net Profit Margin
13.62%
↑ 4.06%
FY19Y/Y Change
Revenue
283.4M
↑ 3.51%
Net Income
37.7M
↑ 1.23%
Net Profit Margin
13.32%
↓ 0.3%
FY20Y/Y Change
Revenue
284.1M
↑ 0.25%
Net Income
25.9M
↓ 31.5%
Net Profit Margin
9.1%
↓ 4.22%
FY21Y/Y Change
Revenue
309.2M
↑ 8.83%
Net Income
30.6M
↑ 18.38%
Net Profit Margin
9.9%
↑ 0.8%
FY22Y/Y Change
Revenue
273.4M
↓ 11.58%
Net Income
21.1M
↓ 31.05%
Net Profit Margin
7.72%
↓ 2.18%
FY23Y/Y Change
Revenue
256.9M
↓ 6.06%
Net Income
233.0K
↓ 98.9%
Net Profit Margin
0.09%
↓ 7.63%
Q4 FY22Q/Q Change
Revenue
58.9M
↓ 9.98%
Net Income
-19.0K
↓ 100.74%
Net Profit Margin
-0.03%
↓ 3.97%
Q1 FY23Q/Q Change
Revenue
62.4M
↑ 6.01%
Net Income
-5.1M
↑ 26752.63%
Net Profit Margin
-8.18%
↓ 8.15%
Q2 FY23Q/Q Change
Revenue
78.2M
↑ 25.38%
Net Income
-887.0K
↓ 82.61%
Net Profit Margin
-1.13%
↑ 7.05%
Q3 FY23Q/Q Change
Revenue
71.0M
↓ 9.26%
Net Income
-70.0K
↓ 92.11%
Net Profit Margin
-0.1%
↑ 1.03%
Q4 FY23Q/Q Change
Revenue
65.3M
↓ 8.0%
Net Income
-2.0M
↑ 2795.71%
Net Profit Margin
-3.1%
↓ 3.0%
Q1 FY24Q/Q Change
Revenue
65.3M
↑ 0.0%
Net Income
-2.0M
↑ 0.0%
Net Profit Margin
-3.1%
↑ 0.0%
FY18Y/Y Change
Total Assets
134.8M
↑ 19.53%
Total Liabilities
19.1M
↓ 1.74%
FY19Y/Y Change
Total Assets
154.4M
↑ 14.53%
Total Liabilities
19.7M
↑ 3.36%
FY20Y/Y Change
Total Assets
155.3M
↑ 0.58%
Total Liabilities
25.3M
↑ 28.19%
FY21Y/Y Change
Total Assets
187.5M
↑ 20.71%
Total Liabilities
46.2M
↑ 82.58%
FY22Y/Y Change
Total Assets
176.3M
↓ 5.96%
Total Liabilities
34.1M
↓ 26.14%
FY23Y/Y Change
Total Assets
164.1M
↓ 6.92%
Total Liabilities
40.3M
↑ 18.13%
Q4 FY22Q/Q Change
Total Assets
165.1M
↓ 2.45%
Total Liabilities
31.5M
↑ 1.36%
Q1 FY23Q/Q Change
Total Assets
164.1M
↓ 0.61%
Total Liabilities
40.3M
↑ 27.86%
Q2 FY23Q/Q Change
Total Assets
180.7M
↑ 10.13%
Total Liabilities
62.4M
↑ 54.79%
Q3 FY23Q/Q Change
Total Assets
159.3M
↓ 11.88%
Total Liabilities
45.6M
↓ 26.94%
Q4 FY23Q/Q Change
Total Assets
173.4M
↑ 8.84%
Total Liabilities
73.3M
↑ 60.72%
Q1 FY24Q/Q Change
Total Assets
173.4M
↑ 0.0%
Total Liabilities
73.3M
↑ 0.0%
FY18Y/Y Change
Operating Cash Flow
37.4M
↓ 20.81%
Investing Cash Flow
-703.0K
↓ 93.37%
Financing Cash Flow
-17.5M
↑ 12.64%
FY19Y/Y Change
Operating Cash Flow
45.1M
↑ 20.76%
Investing Cash Flow
-620.0K
↓ 11.81%
Financing Cash Flow
-21.9M
↑ 25.5%
FY20Y/Y Change
Operating Cash Flow
38.8M
↓ 13.94%
Investing Cash Flow
-2.3M
↑ 272.74%
Financing Cash Flow
-33.3M
↑ 51.88%
FY21Y/Y Change
Operating Cash Flow
40.1M
↑ 3.17%
Investing Cash Flow
-2.4M
↑ 5.24%
Financing Cash Flow
-22.7M
↓ 31.87%
FY22Y/Y Change
Operating Cash Flow
18.5M
↓ 53.84%
Investing Cash Flow
-1.8M
↓ 27.96%
Financing Cash Flow
-24.4M
↑ 7.48%
FY23Y/Y Change
Operating Cash Flow
27.8M
↑ 50.3%
Investing Cash Flow
-10.3M
↑ 485.62%
Financing Cash Flow
-24.5M
↑ 0.63%
Q4 FY22Q/Q Change
Operating Cash Flow
13.0M
↓ 1119.73%
Investing Cash Flow
-993.0K
↓ 26.66%
Financing Cash Flow
-6.1M
↓ 2.34%
Q1 FY23Q/Q Change
Operating Cash Flow
9.7M
↓ 25.03%
Investing Cash Flow
-1.9M
↑ 94.46%
Financing Cash Flow
-6.1M
↑ 0.64%
Q2 FY23Q/Q Change
Operating Cash Flow
562.0K
↓ 94.22%
Investing Cash Flow
-37.0M
↑ 1816.73%
Financing Cash Flow
-6.1M
↓ 0.54%

Technicals Summary

Sell

Neutral

Buy

Petmed Express Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Petmed Express Inc
Petmed Express Inc
-11.34%
-58.38%
-72.98%
-86.27%
-81.08%
Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc.
-14.79%
-17.04%
-50.45%
-67.22%
-67.73%
Bimi International Medical Inc
Bimi International Medical Inc
-47.7%
-11.75%
117.23%
-98.04%
-99.31%
High Tide Inc
High Tide Inc
30.23%
39.13%
65.93%
-75.11%
-75.11%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Petmed Express Inc
Petmed Express Inc
1191.0
NA
2.58
-0.04
-0.05
-0.03
0.13
5.57
Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc.
27.42
NA
1.98
3.23
-0.57
0.01
0.06
15.63
Bimi International Medical Inc
Bimi International Medical Inc
NA
NA
NA
0.0
-1.04
-0.13
NA
1.31
High Tide Inc
High Tide Inc
NA
NA
NA
-0.02
-0.24
0.01
NA
1.75
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Petmed Express Inc
Petmed Express Inc
Sell
$88.2M
-81.08%
1191.0
-2.25%
Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc.
Hold
$15.2B
-67.73%
27.42
-4.18%
Bimi International Medical Inc
Bimi International Medical Inc
NA
$22.3M
-99.31%
NA
-83.2%
High Tide Inc
High Tide Inc
Buy
$176.3M
-75.11%
NA
-7.18%

Institutional Holdings

  • BlackRock Inc

    8.42%

  • Renaissance Technologies Corp

    6.36%

  • Vanguard Group Inc

    5.57%

  • Hotchkis & Wiley Capital Management LLC

    3.50%

  • Millennium Management LLC

    3.45%

  • Dimensional Fund Advisors, Inc.

    2.75%

Corporate Announcements

  • Petmed Express Inc Dividends March,2023

    In the quarter ending March,2023. Petmed Express Inc has declared dividend of $0.3

    Read More

Company Information

petmeds® is america's largest pet pharmacy, a publicly traded company (nasdaq: pets). we deliver prescription and non-prescription pet meds along with health and nutritional supplements for dogs, cats and horses at substantial savings directly to you. we serve millions of satisfied customers nationwide from one location.

Organization
Petmed Express Inc
Employees
302
CEO
Mr. Mathew N. Hulett
Industry
Retail Trade

Discover More

FAQs